health canada approval zepbound tirzepatide obesity canada 2024 2025 has approved Wegovy® (semaglutide) for the treatment of MASH (non-cirrhotic metabolic dysfunction-associated steatohepatitis) — a serious liver disease that is one of many downstream conditions related to obesity. As many Health Canada Approves Zepbound for

Enriched with powerful antioxidants such as Glutathione, Alpha Lipoic Acid, and other skin-nourishing ingredients, it works to detoxify the body, reduce oxidative stress, and support an even skin tone

Saxenda is approved for weight loss when used with diet and exercise

Its extremely important not to skip the starter dose step or adjust your dose to a higher dose without staying on a dose for a minimum of 4 weeks

Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects